{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:24:08Z","timestamp":1791905048487,"version":"4.3.4"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2023201026"],"award-info":[{"award-number":["H2023201026"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2022201035"],"award-info":[{"award-number":["H2022201035"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["236Z2406G"],"award-info":[{"award-number":["236Z2406G"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["20567 605H"],"award-info":[{"award-number":["20567 605H"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113904","type":"journal-article","created":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T19:43:47Z","timestamp":1735155827000},"page":"113904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Efferocytosis: A new star of atherosclerotic plaques reversal"],"prefix":"10.1016","volume":"146","author":[{"given":"Xiangyu","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuoqi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiameng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1632-5956","authenticated-orcid":false,"given":"Zhongcheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2024.113904_b0005","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.immuni.2019.04.018","article-title":"Living on the Edge: Efferocytosis at the Interface of Homeostasis and Pathology","volume":"50","author":"Morioka","year":"2019","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.intimp.2024.113904_b0010","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s10495-010-0509-5","article-title":"A model to die for: signaling to apoptotic cell removal in worm, fly and mouse","volume":"15","author":"Kinchen","year":"2010","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.intimp.2024.113904_b0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mehy.2004.01.029","article-title":"Atheroscleritis is a more rational term for the pathological entity currently known as atherosclerosis","volume":"63","author":"Li","year":"2004","journal-title":"Med Hypotheses"},{"issue":"9873","key":"10.1016\/j.intimp.2024.113904_b0020","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(13)60598-X","article-title":"Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations","volume":"381","author":"Thompson","year":"2013","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.intimp.2024.113904_b0025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCRESAHA.109.208389","article-title":"Vascular smooth muscle cell apoptosis induces interleukin-1-directed inflammation: effects of hyperlipidemia-mediated inhibition of phagocytosis","volume":"106","author":"Clarke","year":"2010","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.intimp.2024.113904_b0030","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1189\/jlb.0209115","article-title":"Mechanisms and consequences of efferocytosis in advanced atherosclerosis","volume":"86","author":"Thorp","year":"2009","journal-title":"J Leukoc Biol"},{"issue":"6","key":"10.1016\/j.intimp.2024.113904_b0035","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/01.ATV.0000166517.18801.a7","article-title":"Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis","volume":"25","author":"Schrijvers","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.intimp.2024.113904_b0040","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1253\/circj.CJ-16-0924","article-title":"Macrophage apoptosis and efferocytosis in the pathogenesis of atherosclerosis","volume":"80","author":"Linton","year":"2016","journal-title":"Circulation Journal"},{"issue":"16","key":"10.1016\/j.intimp.2024.113904_b0045","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","article-title":"Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications","volume":"116","author":"Tabas","year":"2007","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.intimp.2024.113904_b0050","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0531-5565(99)00035-2","article-title":"Atherosclerosis\u2014An autoimmune disease!","volume":"34","author":"Wick","year":"1999","journal-title":"Experimental gerontology"},{"issue":"3","key":"10.1016\/j.intimp.2024.113904_b0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2024.113904_b0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri2675","article-title":"Macrophage death and defective inflammation resolution in atherosclerosis","volume":"10","author":"Tabas","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.intimp.2024.113904_b0065","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00001573-200109000-00006","article-title":"The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes","volume":"16","author":"Kolodgie","year":"2001","journal-title":"Curr Opin Cardiol"},{"issue":"6","key":"10.1016\/j.intimp.2024.113904_b0070","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1172\/JCI117619","article-title":"Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques","volume":"94","author":"Galis","year":"1994","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.intimp.2024.113904_b0075","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1161\/ATVBAHA.111.231563","article-title":"Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis","volume":"31","author":"Quillard","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"16","key":"10.1016\/j.intimp.2024.113904_b0080","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/hc4101.097419","article-title":"Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling","volume":"104","author":"Herman","year":"2001","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.intimp.2024.113904_b0085","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1161\/01.ATV.0000086961.44581.B7","article-title":"Tumor necrosis factor-alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms","volume":"23","author":"Boyle","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113904_b0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"4","key":"10.1016\/j.intimp.2024.113904_b0095","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41569-021-00629-x","article-title":"Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis","volume":"19","author":"Chen","year":"2022","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"10.1016\/j.intimp.2024.113904_b0100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/MOL.0b013e32834a97e4","article-title":"Phenotypic modulation of macrophages in response to plaque lipids","volume":"22","author":"Adamson","year":"2011","journal-title":"Curr Opin Lipidol"},{"issue":"5\u20136","key":"10.1016\/j.intimp.2024.113904_b0105","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1159\/000336618","article-title":"Macrophage differentiation and function in atherosclerosis: opportunities for therapeutic intervention?","volume":"4","author":"Williams","year":"2012","journal-title":"J Innate Immun"},{"issue":"1","key":"10.1016\/j.intimp.2024.113904_b0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1172\/JCI29950","article-title":"Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata","volume":"117","author":"Swirski","year":"2007","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.intimp.2024.113904_b0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113904_b0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nrcardio.2014.173","article-title":"Macrophage subsets in atherosclerosis","volume":"12","author":"Chinetti-Gbaguidi","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.intimp.2024.113904_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2017.08.021","article-title":"CXCL4-induced macrophages in human atherosclerosis","volume":"122","author":"Domschke","year":"2019","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.intimp.2024.113904_b0130","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.intimp.2024.113904_b0135","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2012.09.013","article-title":"Distribution of macrophage polarization markers in human atherosclerosis","volume":"225","author":"St\u00f6ger","year":"2012","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.intimp.2024.113904_b0140","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.11.020","article-title":"The phenotype of infiltrating macrophages influences arteriosclerotic plaque vulnerability in the carotid artery","volume":"22","author":"Cho","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"6","key":"10.1016\/j.intimp.2024.113904_b0145","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/CIRCRESAHA.109.215715","article-title":"Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2","volume":"107","author":"Kadl","year":"2010","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.intimp.2024.113904_b0150","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00018-019-03371-3","article-title":"Diversity of macrophage phenotypes and responses in atherosclerosis","volume":"77","author":"Jinnouchi","year":"2020","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"10.1016\/j.intimp.2024.113904_b0155","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.111.032268","article-title":"Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependent","volume":"124","author":"Yancey","year":"2011","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.intimp.2024.113904_b0160","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1194\/jlr.M056689","article-title":"Macrophage SR-BI mediates efferocytosis via Src\/PI3K\/Rac1 signaling and reduces atherosclerotic lesion necrosis","volume":"56","author":"Tao","year":"2015","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.intimp.2024.113904_b0165","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCULATIONAHA.113.005991","article-title":"ERK5 activation in macrophages promotes efferocytosis and inhibits atherosclerosis","volume":"130","author":"Heo","year":"2014","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.intimp.2024.113904_b0170","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41577-019-0167-y","article-title":"How macrophages deal with death","volume":"19","author":"Lemke","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.intimp.2024.113904_b0175","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.molcel.2021.02.025","article-title":"Caspase cleavage releases a nuclear protein fragment that stimulates phospholipid scrambling at the plasma membrane","volume":"81","author":"Maruoka","year":"2021","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/j.intimp.2024.113904_b0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.devcel.2016.06.029","article-title":"The Dynamics of Apoptotic Cell Clearance","volume":"38","author":"Elliott","year":"2016","journal-title":"Dev Cell"},{"issue":"6","key":"10.1016\/j.intimp.2024.113904_b0185","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nri2974","article-title":"The outs and the ins of sphingosine-1-phosphate in immunity","volume":"11","author":"Spiegel","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"26","key":"10.1016\/j.intimp.2024.113904_b0190","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn8048","article-title":"Activation of the human chemokine receptor CX3CR1 regulated by cholesterol","volume":"8","author":"Lu","year":"2022","journal-title":"Sci Adv"},{"issue":"8","key":"10.1016\/j.intimp.2024.113904_b0195","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41573-022-00470-y","article-title":"Drugging the efferocytosis process: concepts and opportunities","volume":"21","author":"Mehrotra","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.intimp.2024.113904_b0200","first-page":"20","article-title":"Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin","volume":"119","author":"Bournazou","year":"2009","journal-title":"J Clin Invest"},{"issue":"6144","key":"10.1016\/j.intimp.2024.113904_b0205","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.1236758","article-title":"Xk-related protein 8 and CED-8 promote phosphatidylserine exposure in apoptotic cells","volume":"341","author":"Suzuki","year":"2013","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.intimp.2024.113904_b0210","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/cdd.2016.11","article-title":"Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer","volume":"23","author":"Birge","year":"2016","journal-title":"Cell Death Differ"},{"issue":"2","key":"10.1016\/j.intimp.2024.113904_b0215","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.immuni.2020.07.008","article-title":"CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis","volume":"53","author":"Morrissey","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.113904_b0220","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.critrevonc.2017.01.006","article-title":"Regulatory roles of brain-specific angiogenesis inhibitor 1(BAI1) protein in inflammation, tumorigenesis and phagocytosis: A brief review","volume":"111","author":"Mathema","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.intimp.2024.113904_b0225","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1038\/ncomms5046","article-title":"Distinct roles for BAI1 and TIM-4 in the engulfment of dying neurons by microglia","volume":"5","author":"Mazaheri","year":"2014","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.intimp.2024.113904_b0230","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1038\/emm.2017.52","article-title":"Engulfment signals and the phagocytic machinery for apoptotic cell clearance","volume":"49","author":"Park","year":"2017","journal-title":"Exp Mol Med"},{"issue":"6","key":"10.1016\/j.intimp.2024.113904_b0235","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1083\/jcb.201701074","article-title":"WASP and SCAR are evolutionarily conserved in actin-filled pseudopod-based motility","volume":"216","author":"Fritz-Laylin","year":"2017","journal-title":"J Cell Biol"},{"key":"10.1016\/j.intimp.2024.113904_b0240","first-page":"1","article-title":"Prix Fixe: Efferocytosis as a Four-Course Meal","volume":"403","author":"Martinez","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113904_b0245","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008748","article-title":"Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion","volume":"5","author":"Hochreiter-Hufford","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113904_b0250","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1097-2765(01)00164-2","article-title":"A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis","volume":"7","author":"Chawla","year":"2001","journal-title":"Mol Cell"},{"issue":"3","key":"10.1016\/j.intimp.2024.113904_b0255","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0008-6363(99)00235-7","article-title":"Apoptosis in atherosclerosis: beneficial or detrimental?","volume":"45","author":"Kockx","year":"2000","journal-title":"Cardiovasc Res"},{"issue":"9","key":"10.1016\/j.intimp.2024.113904_b0260","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/nm1459","article-title":"Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis","volume":"12","author":"Clarke","year":"2006","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.intimp.2024.113904_b0265","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1172\/JCI70391","article-title":"Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis","volume":"124","author":"Kojima","year":"2014","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.intimp.2024.113904_b0270","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1073\/pnas.1424907112","article-title":"Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and Btk","volume":"112","author":"Feng","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7614","key":"10.1016\/j.intimp.2024.113904_b0275","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature18935","article-title":"CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis","volume":"536","author":"Kojima","year":"2016","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.intimp.2024.113904_b0280","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1378\/chest.129.6.1673","article-title":"Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease","volume":"129","author":"Vandivier","year":"2006","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.intimp.2024.113904_b0285","doi-asserted-by":"crossref","first-page":"8117","DOI":"10.4049\/jimmunol.178.12.8117","article-title":"TNF-alpha inhibits macrophage clearance of apoptotic cells via cytosolic phospholipase A2 and oxidant-dependent mechanisms","volume":"178","author":"McPhillips","year":"2007","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113904_b0290","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1083\/jcb.201412052","article-title":"Recent insights into the cellular biology of atherosclerosis","volume":"209","author":"Tabas","year":"2015","journal-title":"J Cell Biol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113904_b0295","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41590-017-0004-z","article-title":"Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy","volume":"19","author":"Barkal","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2024.113904_b0300","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.carbpol.2016.04.044","article-title":"The linear structure of \u03b2-glucan from baker's yeast and its activation of macrophage-like RAW264.7 cells","volume":"148","author":"Zheng","year":"2016","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.intimp.2024.113904_b0305","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.ijbiomac.2014.09.057","article-title":"Polysaccharides from Umbilicaria esculenta cultivated in Huangshan Mountain and immunomodulatory activity","volume":"72","author":"Du","year":"2015","journal-title":"Int J Biol Macromol"},{"issue":"suppl 3","key":"10.1016\/j.intimp.2024.113904_b0310","doi-asserted-by":"crossref","first-page":"iii25","DOI":"10.1136\/ard.60.90003.iii25","article-title":"Biology of TACE inhibition","volume":"60","author":"Newton","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.intimp.2024.113904_b0315","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1165\/rcmb.2007-0306OC","article-title":"Overexpression of apoptotic cell removal receptor MERTK in alveolar macrophages of cigarette smokers","volume":"39","author":"Kazeros","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.intimp.2024.113904_b0320","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0092-8674(95)90520-0","article-title":"The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3\/Axl family of receptor tyrosine kinases","volume":"80","author":"Stitt","year":"1995","journal-title":"Cell"},{"issue":"38","key":"10.1016\/j.intimp.2024.113904_b0325","doi-asserted-by":"crossref","first-page":"33335","DOI":"10.1074\/jbc.M111.263020","article-title":"Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase C\u03b4, and p38 mitogen-activated protein kinase (MAPK)","volume":"286","author":"Thorp","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2024.113904_b0330","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1172\/JCI90520","article-title":"MERTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis","volume":"127","author":"Cai","year":"2017","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.intimp.2024.113904_b0335","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/cvr\/cvs301","article-title":"Expansion of necrotic core and shedding of Mertk receptor in human carotid plaques: a role for oxidized polyunsaturated fatty acids?","volume":"97","author":"Garbin","year":"2013","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.intimp.2024.113904_b0340","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2006-05-021634","article-title":"A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation","volume":"109","author":"Sather","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.intimp.2024.113904_b0345","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/CIRCRESAHA.115.306256","article-title":"Macrophage Phenotype and Function in Different Stages of Atherosclerosis","volume":"118","author":"Tabas","year":"2016","journal-title":"Circ Res"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.113904_b0350","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cca.2011.08.021","article-title":"Toll-like receptors and macrophage activation in atherosclerosis","volume":"413","author":"Seneviratne","year":"2012","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.intimp.2024.113904_b0355","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.atherosclerosis.2012.12.021","article-title":"Lipopolysaccharide downregulates CD91\/low-density lipoprotein receptor-related protein 1 expression through SREBP-1 overexpression in human macrophages","volume":"227","author":"Costales","year":"2013","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.intimp.2024.113904_b0360","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1189\/jlb.0410220","article-title":"Inflammatory mediators promote production of shed LRP1\/CD91, which regulates cell signaling and cytokine expression by macrophages","volume":"88","author":"Gorovoy","year":"2010","journal-title":"J Leukoc Biol"},{"issue":"4","key":"10.1016\/j.intimp.2024.113904_b0365","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/ATVBAHA.109.202051","article-title":"Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation","volume":"30","author":"Yancey","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.intimp.2024.113904_b0370","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.RES.0000260204.40510.aa","article-title":"Deletion of macrophage LDL receptor-related protein increases atherogenesis in the mouse","volume":"100","author":"Overton","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.intimp.2024.113904_b0375","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cca.2017.01.013","article-title":"Reduced serum milk fat globule-epidermal growth factor 8 (MFG-E8) concentrations are associated with an increased risk of microvascular complications in patients with type 2 diabetes","volume":"466","author":"Sun","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.intimp.2024.113904_b0380","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fcvm.2017.00086","article-title":"Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis","volume":"4","author":"Yurdagul","year":"2017","journal-title":"Front Cardiovasc Med"},{"issue":"6885","key":"10.1016\/j.intimp.2024.113904_b0385","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/417182a","article-title":"Identification of a factor that links apoptotic cells to phagocytes","volume":"417","author":"Hanayama","year":"2002","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.intimp.2024.113904_b0390","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.4049\/jimmunol.0803444","article-title":"Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells","volume":"182","author":"T\u00f3th","year":"2009","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113904_b0395","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4049\/jimmunol.1601445","article-title":"Complement Protein C1q Enhances Macrophage Foam Cell Survival and Efferocytosis","volume":"198","author":"Pulanco","year":"2017","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.intimp.2024.113904_b0400","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1161\/01.ATV.0000145573.36113.8a","article-title":"Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines","volume":"24","author":"Kalinina","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.intimp.2024.113904_b0405","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/ATVBAHA.110.218669","article-title":"High-mobility group box protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein e-deficient mice","volume":"31","author":"Kanellakis","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.intimp.2024.113904_b0410","doi-asserted-by":"crossref","first-page":"C1267","DOI":"10.1152\/ajpcell.00152.2010","article-title":"HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin","volume":"299","author":"Friggeri","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"10.1016\/j.intimp.2024.113904_b0415","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.4049\/jimmunol.181.6.4240","article-title":"High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine","volume":"181","author":"Liu","year":"2008","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.intimp.2024.113904_b0420","doi-asserted-by":"crossref","first-page":"E2801","DOI":"10.1073\/pnas.1707929115","article-title":"Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition","volume":"115","author":"Giurisato","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.intimp.2024.113904_b0425","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.15252\/emmm.201607492","article-title":"Macrophage deficiency of miR-21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis","volume":"9","author":"Canfr\u00e1n-Duque","year":"2017","journal-title":"EMBO Mol Med"},{"issue":"9","key":"10.1016\/j.intimp.2024.113904_b0430","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0022-2275(20)30281-9","article-title":"Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein","volume":"42","author":"Gillotte-Taylor","year":"2001","journal-title":"J Lipid Res"},{"issue":"12","key":"10.1016\/j.intimp.2024.113904_b0435","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/ATVBAHA.114.304023","article-title":"Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis","volume":"34","author":"Marsch","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113904_b0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170307","article-title":"Low Cytochrome Oxidase 1 Links Mitochondrial Dysfunction to Atherosclerosis in Mice and Pigs","volume":"12","author":"Holvoet","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.intimp.2024.113904_b0445","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.rmed.2005.03.035","article-title":"Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study","volume":"100","author":"Mannino","year":"2006","journal-title":"Respir Med"},{"issue":"11","key":"10.1016\/j.intimp.2024.113904_b0450","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/intimm\/dxt033","article-title":"Cigarette smoke impairs phagocytosis of apoptotic neutrophils by alveolar macrophages via inhibition of the histone deacetylase\/Rac\/CD9 pathways","volume":"25","author":"Noda","year":"2013","journal-title":"Int Immunol"},{"issue":"12","key":"10.1016\/j.intimp.2024.113904_b0455","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.4049\/jimmunol.176.12.7657","article-title":"Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease","volume":"176","author":"Morimoto","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113904_b0460","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5551\/jat.37747","article-title":"Endothelial Nitric Oxide Synthase-Independent Pleiotropic Effects of Pitavastatin Against Atherogenesis and Limb Ischemia in Mice","volume":"25","author":"Mitsuhashi","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.intimp.2024.113904_b0465","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1476-511X-9-16","article-title":"Regulations of the key mediators in inflammation and atherosclerosis by aspirin in human macrophages","volume":"9","author":"Lu","year":"2010","journal-title":"Lipids Health Dis"},{"issue":"8","key":"10.1016\/j.intimp.2024.113904_b0470","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3181\/0703-MR-54","article-title":"Macrophage iron, hepcidin, and atherosclerotic plaque stability","volume":"232","author":"Sullivan","year":"2007","journal-title":"Exp Biol Med (Maywood)"},{"issue":"2","key":"10.1016\/j.intimp.2024.113904_b0475","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1164\/rccm.200711-1666OC","article-title":"Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease","volume":"178","author":"Hodge","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.intimp.2024.113904_b0480","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.731769","article-title":"Guanxinkang Decoction Attenuates the Inflammation in Atherosclerosis by Regulating Efferocytosis and MAPKs Signaling Pathway in LDLR(-\/-) Mice and RAW264.7 Cells","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Pharmacol"},{"issue":"43","key":"10.1016\/j.intimp.2024.113904_b0485","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4103\/0973-1296.160454","article-title":"A direct protein kinase B-targeted anti-inflammatory activity of cordycepin from artificially cultured fruit body of Cordyceps militaris","volume":"11","author":"Yoon","year":"2015","journal-title":"Pharmacogn Mag"},{"key":"10.1016\/j.intimp.2024.113904_b0490","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.carbpol.2014.11.059","article-title":"Mechanism of macrophage activation induced by polysaccharide from Cordyceps militaris culture broth","volume":"120","author":"Lee","year":"2015","journal-title":"Carbohydr Polym"},{"issue":"9","key":"10.1016\/j.intimp.2024.113904_b0495","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.intimp.2011.04.001","article-title":"Immunostimulating activity of the polysaccharides isolated from Cordyceps militaris","volume":"11","author":"Lee","year":"2011","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113904_b0500","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/CIRCRESAHA.114.302355","article-title":"Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies","volume":"114","author":"Silvestre-Roig","year":"2014","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.intimp.2024.113904_b0505","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jacbts.2016.07.005","article-title":"CD47-Blocking Antibodies andAtherosclerosis","volume":"1","author":"Ryan","year":"2016","journal-title":"JACC Basic Transl Sci"},{"issue":"2","key":"10.1016\/j.intimp.2024.113904_b0510","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41418-019-0370-1","article-title":"Resolvin D1 promotes the targeting and clearance of necroptotic cells","volume":"27","author":"Gerlach","year":"2020","journal-title":"Cell Death Differ"},{"issue":"20","key":"10.1016\/j.intimp.2024.113904_b0515","doi-asserted-by":"crossref","first-page":"18013","DOI":"10.1074\/jbc.M111.221028","article-title":"Crystal structure of leukocyte Ig-like receptor LILRB4 (ILT3\/LIR-5\/CD85k): a myeloid inhibitory receptor involved in immune tolerance","volume":"286","author":"Cheng","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2024.113904_b0520","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1160\/TH16-09-0674","article-title":"Contrasting effects of myeloid and endothelial ADAM17 on atherosclerosis development","volume":"117","author":"van der Vorst","year":"2017","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.intimp.2024.113904_b0525","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1172\/JCI43802","article-title":"Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-\/- mice during disease regression","volume":"121","author":"Potteaux","year":"2011","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.intimp.2024.113904_b0530","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/ATVBAHA.114.303565","article-title":"Monocyte fate in atherosclerosis","volume":"35","author":"Hilgendorf","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.intimp.2024.113904_b0535","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1084\/jem.20091293","article-title":"Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile","volume":"207","author":"Lutgens","year":"2010","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.intimp.2024.113904_b0540","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41551-018-0221-2","article-title":"Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates","volume":"2","author":"Lameijer","year":"2018","journal-title":"Nat Biomed Eng"},{"issue":"6035","key":"10.1016\/j.intimp.2024.113904_b0545","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1126\/science.1204351","article-title":"Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation","volume":"332","author":"Jenkins","year":"2011","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.intimp.2024.113904_b0550","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/nm.3258","article-title":"Local proliferation dominates lesional macrophage accumulation in atherosclerosis","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.intimp.2024.113904_b0555","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1400223","article-title":"Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation","volume":"1","author":"Tang","year":"2015","journal-title":"Sci Adv"},{"key":"10.1016\/j.intimp.2024.113904_b0560","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1038\/ncomms4065","article-title":"A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation","volume":"5","author":"Duivenvoorden","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.intimp.2024.113904_b0565","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jconrel.2017.07.013","article-title":"A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis","volume":"262","author":"Alaarg","year":"2017","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.intimp.2024.113904_b0570","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41565-019-0619-3","article-title":"Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis","volume":"15","author":"Flores","year":"2020","journal-title":"Nat Nanotechnol"},{"issue":"3","key":"10.1016\/j.intimp.2024.113904_b0575","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1172\/JCI120123","article-title":"Alternative macrophages in atherosclerosis: not always protective!","volume":"128","author":"Pourcet","year":"2018","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.intimp.2024.113904_b0580","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.intimp.2024.113904_b0585","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.7150\/ijbs.71862","article-title":"Exosomes in atherosclerosis: Convergence on macrophages","volume":"18","author":"Yang","year":"2022","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.intimp.2024.113904_b0590","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.715461","article-title":"The Biogenesis, Biological Functions, and Applications of Macrophage-Derived Exosomes","volume":"8","author":"Shan","year":"2021","journal-title":"Front Mol Biosci"},{"issue":"2","key":"10.1016\/j.intimp.2024.113904_b0595","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00395-020-0781-7","article-title":"M1-like macrophage-derived exosomes suppress angiogenesis and exacerbate cardiac dysfunction in a myocardial infarction microenvironment","volume":"115","author":"Liu","year":"2020","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"10.1016\/j.intimp.2024.113904_b0600","first-page":"4605","article-title":"Exosomes derived from oxidized LDL-stimulated macrophages attenuate the growth and tube formation of endothelial cells","volume":"17","author":"Huang","year":"2018","journal-title":"Mol Med Rep"},{"issue":"2","key":"10.1016\/j.intimp.2024.113904_b0605","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/imm.12910","article-title":"Implications of macrophage polarization in autoimmunity","volume":"154","author":"Funes","year":"2018","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.intimp.2024.113904_b0610","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/PL00001954","article-title":"Immune responses to Chlamydia antigens in atherosclerosis","volume":"25","author":"Gaston","year":"2000","journal-title":"Herz"},{"issue":"5","key":"10.1016\/j.intimp.2024.113904_b0615","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.freeradbiomed.2009.12.019","article-title":"Nitric oxide synthase-2 regulates mitochondrial Hsp60 chaperone function during bacterial peritonitis in mice","volume":"48","author":"Suliman","year":"2010","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.intimp.2024.113904_b0620","first-page":"259","article-title":"Characterization of heat shock protein-specific T cells in atherosclerosis","volume":"12","author":"Ford","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"3","key":"10.1016\/j.intimp.2024.113904_b0625","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058364","article-title":"Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)\/J mice","volume":"8","author":"Mundkur","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.intimp.2024.113904_b0630","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.cmet.2020.01.001","article-title":"Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of Injury","volume":"31","author":"Yurdagul","year":"2020","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.intimp.2024.113904_b0635","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cmet.2022.12.005","article-title":"Metabolic adaptation supports enhanced macrophage efferocytosis in limited-oxygen environments","volume":"35","author":"Wang","year":"2023","journal-title":"Cell Metab"},{"issue":"22","key":"10.1016\/j.intimp.2024.113904_b0640","doi-asserted-by":"crossref","first-page":"e707","DOI":"10.1161\/CIRCULATIONAHA.108.789818","volume":"118","author":"Sutton","year":"2008","journal-title":"Circulation"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924024263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924024263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:58:41Z","timestamp":1778619521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924024263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":128,"alternative-id":["S1567576924024263"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113904","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efferocytosis: A new star of atherosclerotic plaques reversal","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113904"}}